OneMedNetONMD
ONMD
About: OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.
Employees: 22
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
2.37% more ownership
Funds ownership: 15.31% [Q4 2024] → 17.68% (+2.37%) [Q1 2025]
0% more funds holding
Funds holding: 17 [Q4 2024] → 17 (+0) [Q1 2025]
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
54% less capital invested
Capital invested by funds: $5.83M [Q4 2024] → $2.67M (-$3.16M) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for ONMD.
Financial journalist opinion
Neutral
GlobeNewsWire
2 weeks ago
OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting Strategic Progress
MINNEAPOLIS, June 25, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced today that Aaron Green, President and CEO, issued the following letter to shareholders and other stakeholders of the Company: Dear OneMedNet Shareholders, Partners, and Family, Following a year of significant progress, OneMedNet is navigating 2025 with strong momentum, making substantial strides in expanding our market presence, enhancing our Real-World Data platform, and developing an AI driven tool set to anonymize and De-identify data across multiple industries. My leadership team and I feel it is important that you know our key achievements, including onboarding five major data marketplaces, surpassing 121 million clinical exams in our network, and charting the path forward as we capitalize on the growing demand for de-identified data starting with regulatory-grade RWD.
Neutral
GlobeNewsWire
2 weeks ago
OneMedNet Announces Additional $3.7 Million of Funding in Private Placement Transactions and Approximately $11 Million in Reductions in Liabilities
MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that it has entered into agreements with accredited investors in private placement transactions at $0.42 per share of common stock that resulted in gross proceeds of approximately $3.7 million, before deducting fees and expenses payable by the Company. Certain Company's founders and directors participated in the private placement transactions.
Neutral
GlobeNewsWire
1 month ago
OneMedNet Enhances Data Discovery and Analytics with the Datavant Connect platform and Amazon Web Service (AWS) Clean Rooms
MINNEAPOLIS, May 13, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading provider of regulatory-grade imaging Real-World Data (iRWD) today has announced its adoption of expanded capabilities within the Datavant Connect platform to accelerate healthcare data discovery, analytics, and partner assessment processes. These new advancements will be presented by Datavant this week at ISPOR 2025, highlighting the importance of secure, scalable, and fit-for-purpose data solutions in driving innovation across healthcare and life sciences.
Neutral
PRNewsWire
2 months ago
OneMedNet's regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™
HealthVerity expands access to advanced imaging data through OneMedNet integration, enhancing evidence generation for life sciences research PHILADELPHIA and MINNEAPOLIS , April 29, 2025 /PRNewswire/ -- HealthVerity, the leader in privacy-protected real-world data exchange, today announced that OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade imaging Real-World Data (iRWD), has joined HealthVerity Marketplace™, making its expansive imaging data now discoverable and available in the nation's largest healthcare and consumer data ecosystem. The integration of OneMedNet's iRWD network—spanning more than 1,400 healthcare systems and provider sites, with over 121 million clinical exams from 31 million unique patients—brings a powerful new data type to HealthVerity Marketplace™.
Neutral
GlobeNewsWire
2 months ago
OneMedNet's regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™
MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that its iRWD solution is now available in HealthVerity Marketplace™, enabling seamless integration of imaging data with broader real-world data (RWD) assets to enhance evidence generation in life sciences research. The OneMedNet iRWD network, which spans more than 1,400 healthcare systems and provider sites and includes over 121 million clinical exams from 31 million unique patients, is now discoverable on the HealthVerity Marketplace™.
Neutral
GlobeNewsWire
2 months ago
OneMedNet and Protege Partner to Advance the Future of AI-Driven Healthcare with Real-Time, Multimodal Data
MINNEAPOLIS, April 23, 2025 (GLOBE NEWSWIRE) -- OneMedNet, a leader in AI-powered Real-World Data, has announced a strategic partnership with Protege, the AI training data platform, to enable real-time access, multimodal patient data for AI developers and researchers. Through this collaboration, OneMedNet's data will be made available via Protege, expanding access to high-quality datasets for building next-generation AI solutions in healthcare.
Neutral
GlobeNewsWire
4 months ago
31 Million Patient Journeys, One Mission
MINNEAPOLIS, March 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet, an AI-powered Real World Data leader, has announced a collaboration with Datavant, a health data platform, to provide access to tokenized, purpose-built data for life sciences and medical research through Datavant's health data ecosystem. Leveraging OneMedNet's network of 31M patients, 121M+ clinical studies—EMR insights like images, ECGs, and notes—this collaboration enables life sciences companies to integrate claims data for a full view of patient journeys tailored to specific diseases.
Neutral
GlobeNewsWire
4 months ago
Dr. Kenneth Alleyne Joins OneMedNet Board of Directors
MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading Real World Data platform powered by AI-driven de-identification, announces the appointment of Dr. Kenneth Alleyne to its Board of Directors. A board-certified orthopedic surgeon specializing in sports medicine, Dr. Alleyne will assume the role of Chair of the Audit Committee, bringing extensive expertise in healthcare, insurance, investment, and corporate governance to the organization.
Neutral
GlobeNewsWire
5 months ago
OneMedNet Regains Compliance with NASDAQ Listing Requirements
MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWD™”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that the Company regained compliance with Nasdaq Listing Rule 5550(b)(2) (the “Rule”) after the market value of the Company's common stock exceeded $35,000,000 for 10 consecutive business days. The Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) confirming compliance with the Rule.
Neutral
GlobeNewsWire
6 months ago
OneMedNet Regains Compliance with NASDAQ Minimum Bid Price Requirements
MINNEAPOLIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWD™”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that the Company regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) after the closing bid price of the Company's common stock was $1.00 per share or greater for 10 consecutive business days. The Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) confirming compliance with the Rule.
Charts implemented using Lightweight Charts™